Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation.

Recent technological advances in nanoscience and material designing have led to the development of point-of-care devices for biomolecule sensing and cancer diagnosis. In situ and portable sensing devices for bedside, diagnosis can effectively improve the patient's clinical outcomes and reduce the mortality rate. Detection of exosomal RNAs by immuno-biochip with increased sensitivity and specificity to diagnose cancer has raised the understanding of the tumor microenvironment and many other technology-based biosensing devices hold great promise for clinical innovations to conquer the unbeatable fort of cancer metastasis. Electrochemical biosensors are the most sensitive category of biomolecule detection sensors with significantly low concentrations down to the atomic level. In this sense, this review addresses the recent advances in cancer detection and diagnosis by developing significant biological sensing devices that are believed to have better sensing potential than existing facilities.

Notch Signaling & MicroRNAs - two tumblers of neurogenesis and Gliomas.

Gliomas are one of the most annihilating types of brain tumours having a high rate of annual incidence worldwide. Notch signaling is an evolutionary conserved pathway that regulates differentiation and development. Aberrations in Notch signalling pathways lead to severe pathological state such as the Gliomas. MicroRNAs (miRNAs) are the tiny molecules less than 200 bps in length and regulate a myriad of cellular processes. Categorically, miRNAs are divided in to oncogenic and tumours suppressor miRNAs. Accumulating data have identified miRNAs, which positively or negatively regulate Notch signaling in Gliomas. Here, we have assessed status of our understanding of the interplay between miRNA-base regulation of Notch signaling in gliomas, interaction between Notch signaling and other signaling cascades and have also discussed use of natural compounds that will help us get closer to personalized medicine for gliomas.

Contamination of heavy metals in poultry eggs: a study presenting relation between heavy metals in feed intake and eggs.

This study aims to quantify heavy metals (Ni, Pb, Zn, Mn, Cr, Cu and Se) in eggs obtained from poultry farms and backyard raised hens by comparing the concentration of metals in their feed intake. Overall, 90 samples of egg and 12 samples of poultry feed (6 each with food and water) were collected from 3 different poultry farms and backyards located in peri-urban areas of Lahore. A di-acid digestion method was adopted for digestion, after which digested samples were analyzed under atomic absorption spectrophotometer. Results showed that the concentration of Pb, Cr and Se in egg white (Pb = 0.6578, Cr = 0.18 and Se = 0.2161), egg yolk (Pb = 0.7011, Cr = 0.2617 and Se = 0.2656), feed (Pb = 2.585, Cr = 1.3039 and Se = 0.9411) and water (Pb = 0.5483, Cr = 0.1006 and Se = 0.3461) were above permissible limits in both poultry farms (study group 1) and backyards (study group 2). The concentration of metals such as Pb, Mn, Cr, Cu and Se in poultry farms eggs were higher than backyard hen eggs, which may be due to the intake of contaminated feed. So, the current study concluded that the higher concentration of metals in eggs has a positive correlation with the intake of feed contaminated with heavy metals.